FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

The vaccine, called FluMist, is a nasal vaccine that's been available since 2003 but given in-clinic by a healthcare provider ...

A new coronavirus subvariant is gaining steam and drawing more attention as a potential threat heading into late autumn and ...

What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.